PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Neuroblastoma D009447 66 associated lipids
Pain D010146 64 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Parkinson Disease D010300 53 associated lipids
Peptic Ulcer D010437 19 associated lipids
Peritonitis D010538 38 associated lipids
Persistent Fetal Circulation Syndrome D010547 1 associated lipids
Pleurisy D010998 20 associated lipids
Polycystic Ovary Syndrome D011085 14 associated lipids
Adenomatous Polyposis Coli D011125 16 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Rossi AG and O'Flaherty JT Prostaglandin binding sites in human polymorphonuclear neutrophils. 1989 Prostaglandins pmid:2549574
Kerr JS et al. Effects of recombinant interleukin-1 beta on phospholipase A2 activity, phospholipase A2 mRNA levels, and eicosanoid formation in rabbit chondrocytes. 1989 Biochem. Biophys. Res. Commun. pmid:2558648
Sakai T et al. Protection by cycloheximide against cytotoxicity induced by vincristine, colchicine, or delta 12-prostaglandin J2 on human osteosarcoma cells. 1989 Cancer Res. pmid:2917351
Phillips GD and Holgate ST Interaction of inhaled LTC4 with histamine and PGD2 on airway caliber in asthma. 1989 J. Appl. Physiol. pmid:2917934
Ban M et al. A flavonoid inhibitor of 5-lipoxygenase inhibits leukotriene production following ischemia in gerbil brain. 1989 Stroke pmid:2919414
Ohuchi K et al. Stimulation of histamine release and arachidonic acid metabolism in rat peritoneal mast cells by thapsigargin, a non-TPA-type tumor promoter. 1989 Biochim. Biophys. Acta pmid:2469475
Hamid-Bloomfield S and Whittle BJ Antagonism of PGD2 vasodepressor responses in the rat in vivo by the novel, selective antagonist, BW A868C. 1989 Br. J. Pharmacol. pmid:2647205
Kuiper J et al. The role of prostaglandins in endotoxin stimulated glycogenolysis in the liver. 1989 Agents Actions pmid:2653002
Amano N et al. The effect of pentobarbital and ether anesthesia on rat brain PGD2 content. 1989 Agressologie pmid:2610292
Shram SI et al. [Preparation and properties of prostaglandin D2 labelled with tritium with high molar radioactivity]. 1989 Bioorg. Khim. pmid:2590255
Yamada K [The effect of prostaglandin D2 on rat testicular testosterone levels]. 1989 Nihon Naibunpi Gakkai Zasshi pmid:2591605
Goto H et al. The role of prostaglandin D2 in the genesis of indomethacin-induced gastric lesions in rats. 1989 Scand. J. Gastroenterol. Suppl. pmid:2595317
Busshardt E et al. Regulation of hepatic parenchymal and non-parenchymal cell function by the diadenine nucleotides Ap3A and Ap4A. 1989 Biochim. Biophys. Acta pmid:2563228
Salari H and Chan-Yeung M Interleukin-1 potentiates antigen-mediated arachidonic acid metabolite formation in mast cells. 1989 Clin. Exp. Allergy pmid:2513105
Chakraborti S et al. Oxidant-mediated activation of phospholipase A2 in pulmonary endothelium. 1989 Am. J. Physiol. pmid:2514605
Trist DG et al. The antagonism by BW A868C of PGD2 and BW245C activation of human platelet adenylate cyclase. 1989 Br. J. Pharmacol. pmid:2466517
Triggiani M et al. Inhibition of histamine and prostaglandin D2 release from human lung mast cells by ciclosporin A. 1989 Int. Arch. Allergy Appl. Immunol. pmid:2468619
Charlesworth EN et al. Cells and secretagogues involved in the human late-phase response. 1989 Int. Arch. Allergy Appl. Immunol. pmid:2468620
Church MK et al. Interaction of neuropeptides with human mast cells. 1989 Int. Arch. Allergy Appl. Immunol. pmid:2468622
Charlesworth EN et al. Cutaneous late-phase response to allergen. Mediator release and inflammatory cell infiltration. 1989 J. Clin. Invest. pmid:2468688
Charlesworth EN et al. Effect of cetirizine on mast cell-mediator release and cellular traffic during the cutaneous late-phase reaction. 1989 J. Allergy Clin. Immunol. pmid:2469708
Church MK et al. Mast cells, neuropeptides and inflammation. 1989 Agents Actions pmid:2473641
van Overveld FJ Mediator release from human lung mast cell subtypes in chronic bronchitis and emphysema. 1989 Agents Actions pmid:2473645
Benyon RC et al. Differential release of histamine and eicosanoids from human skin mast cells activated by IgE-dependent and non-immunological stimuli. 1989 Br. J. Pharmacol. pmid:2474353
Dubertret L et al. Biological and cellular responses to grass pollen in sensitive patients. 1989 Dermatologica pmid:2476344
Wachs M et al. Observations on the pathogenesis of nasal priming. 1989 J. Allergy Clin. Immunol. pmid:2477429
Reiss TF et al. Local mediator release after antigen challenge of a bronchial segment in allergic dogs. 1989 Am. J. Physiol. pmid:2481982
Levi-Schaffer F and Shalit M Differential release of histamine and prostaglandin D2 in rat peritoneal mast cells activated with peptides. 1989 Int. Arch. Allergy Appl. Immunol. pmid:2482257
Beasley RC et al. Effect of a thromboxane receptor antagonist on PGD2- and allergen-induced bronchoconstriction. 1989 J. Appl. Physiol. pmid:2525122
Hayaishi O Prostaglandin D2 and sleep. 1989 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2526481
Watanabe Y et al. Positron emission tomography studies using [11C]ester of prostaglandin D2. 1989 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2526503
Morrow JD et al. Release of markedly increased quantities of prostaglandin D2 in vivo in humans following the administration of nicotinic acid. 1989 Prostaglandins pmid:2475889
Fukushima M et al. Prostaglandin A and J: antitumor and antiviral prostaglandins. 1989 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2526507
Thierauch KH et al. Stable 9 beta- or 11 alpha-halogen-15-cyclohexyl-prostaglandins with high affinity to the PGD2-receptor. 1989 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2526554
Gray PR et al. The role of cyclooxygenase products in the acute airway obstruction and airway hyperreactivity of ponies with heaves. 1989 Am. Rev. Respir. Dis. pmid:2502051
Rodriguez y Baena R et al. Effects of nicardipine on the ex vivo release of eicosanoids after experimental subarachnoid hemorrhage. 1989 J. Neurosurg. pmid:2585083
Marone G Control mechanisms of mediator release in human basophils and mast cells. 1988 Nov-Dec Immunol. Invest. pmid:2465995
Hayaishi O Sleep-wake regulation by prostaglandins D2 and E2. 1988 J. Biol. Chem. pmid:3049580
Tran-Thi TA et al. Net prostaglandin release by perfused rat liver after stimulation with phorbol 12-myristate 13-acetate. 1988 J. Hepatol. pmid:3166024
Casteleijn E et al. Prostaglandin D2 mediates the stimulation of glycogenolysis in the liver by phorbol ester. 1988 Biochem. J. pmid:3162673
Ishioka C et al. Inhibitory effects of prostaglandin A2 on c-myc expression and cell cycle progression in human leukemia cell line HL-60. 1988 Cancer Res. pmid:3162825
Soifer SJ et al. Effects of prostaglandin D2 on pulmonary arterial pressure and oxygenation in newborn infants with persistent pulmonary hypertension. 1988 J. Pediatr. pmid:3162978
Wasserman SI Basic mechanisms in asthma. 1988 Ann Allergy pmid:3163472
Sonoki H et al. [Effects of 3,4-diaminopyridine on the contractions of guinea-pig tracheal smooth muscle induced by histamine and prostaglandin D2]. 1988 Nippon Yakurigaku Zasshi pmid:3163668
Ujihara M et al. Biochemical and immunological demonstration of prostaglandin D2, E2, and F2 alpha formation from prostaglandin H2 by various rat glutathione S-transferase isozymes. 1988 Arch. Biochem. Biophys. pmid:3041912
Foreman D et al. Anhydrolevuglandin D2 inhibits the uterotonic activity of prostaglandins F2 alpha and D2. 1988 Prostaglandins pmid:3163807
Schulman ES et al. Differential effects of the complement peptides, C5a and C5a des Arg on human basophil and lung mast cell histamine release. 1988 J. Clin. Invest. pmid:2449462
Robinson C et al. The immunoglobulin E- and calcium-dependent release of histamine and eicosanoids from human dispersed mastocytosis spleen cells. 1988 J. Invest. Dermatol. pmid:2450144
Holgate ST et al. The contribution of mast cell mediators to acute allergic reactions in human skin and airways. 1988 Allergy pmid:2451448
Schulman ES et al. Density heterogeneity of human lung mast cells. 1988 J. Allergy Clin. Immunol. pmid:2455745